XML 28 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2024
Feb. 23, 2024
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]    
Award Timing MNPI Disclosure
Practices Related to the Grant of Certain Equity Awards
The Company generally maintains a structured equity grant timing process designed to ensure compliance with applicable securities laws, corporate governance best practices, and the avoidance of material nonpublic information (“MNPI”) in granting equity awards. The Compensation Committee generally grants annual equity-based awards to our executive officers in February of each year, in connection with our annual compensation review and approval process, although the exact timing may change from year to year. Our Compensation Committee may also grant equity awards, including RSUs and stock options, at different times of the year for new hires and in connection with promotions, or grants made for retention or other purposes.
 
 
 
 
Stock option exercise prices are set at the closing price of the Company’s common stock on the grant date, in accordance with the Company’s equity plan and applicable securities regulations. This process is designed to prevent any appearance of opportunistic grant timing and to ensure that equity awards are made in a manner that reflects long-term stockholder value creation. Our Compensation Committee does not grant equity awards in anticipation of the release of MNPI and we have not timed the disclosure of MNPI for the purpose of affecting the value of executive compensation. During 2024, the Company granted the following stock options to named executive officers during a period beginning four business days before and ending one business day after the filing of any Company periodic report on Form
10-Q
or Form
10-K,
or the filing or furnishing of any Company current report on Form
8-K
(other than a current report on Form
8-K
disclosing a material new option award grant under Item 5.02(e) of that form) that disclosed any MNPI:
 
Name
   
Grant date
   
Number of
securities
underlying
the award
   
Exercise
price of
the award
   
Grant date
fair value
of the award
   
Percentage change in the
closing market price of the
securities underlying the
award between the trading
day ending immediately
prior to the disclosure of
material nonpublic
information and the trading
day beginning immediately
following the disclosure of
material nonpublic
information
Waleed H. Hassanein, M.D.
        2/23/2024        56,645      $ 83.14        3,040,613        6.70%  
Stephen Gordon
        2/23/2024        18,690      $ 83.14        1,003,249        6.70%  
Nicholas Corcoran
        2/23/2024        17,632      $ 83.14        946,458        6.70%  
Tamer Khayal, M.D.
        2/23/2024        18,690      $ 83.14        1,003,249        6.70%  
  
MNPI Disclosure Timed for Compensation Value false  
Awards Close in Time to MNPI Disclosures, Table
Name
   
Grant date
   
Number of
securities
underlying
the award
   
Exercise
price of
the award
   
Grant date
fair value
of the award
   
Percentage change in the
closing market price of the
securities underlying the
award between the trading
day ending immediately
prior to the disclosure of
material nonpublic
information and the trading
day beginning immediately
following the disclosure of
material nonpublic
information
Waleed H. Hassanein, M.D.
        2/23/2024        56,645      $ 83.14        3,040,613        6.70%  
Stephen Gordon
        2/23/2024        18,690      $ 83.14        1,003,249        6.70%  
Nicholas Corcoran
        2/23/2024        17,632      $ 83.14        946,458        6.70%  
Tamer Khayal, M.D.
        2/23/2024        18,690      $ 83.14        1,003,249        6.70%  
  
Waleed H. Hassanein, M.D. [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Waleed H. Hassanein, M.D.
Underlying Securities | shares   56,645
Exercise Price | $ / shares   $ 83.14
Fair Value as of Grant Date | $   $ 3,040,613
Underlying Security Market Price Change   6.7
Stephen Gordon [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Stephen Gordon
Underlying Securities | shares   18,690
Exercise Price | $ / shares   $ 83.14
Fair Value as of Grant Date | $   $ 1,003,249
Underlying Security Market Price Change   6.7
Nicholas Corcoran [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Nicholas Corcoran
Underlying Securities | shares   17,632
Exercise Price | $ / shares   $ 83.14
Fair Value as of Grant Date | $   $ 946,458
Underlying Security Market Price Change   6.7
Tamer Khayal, M.D. [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Tamer Khayal, M.D.
Underlying Securities | shares   18,690
Exercise Price | $ / shares   $ 83.14
Fair Value as of Grant Date | $   $ 1,003,249
Underlying Security Market Price Change   6.7